🇺🇸 FDA
Patent

US 10519175

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

granted A61KA61K47/36A61K47/38

Quick answer

US patent 10519175 (Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use) held by COMPASS Pathways Limited expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
COMPASS Pathways Limited
Grant date
Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K47/36, A61K47/38, A61K9/0053, A61K9/2054